SCHEMBL3886138

SCHEMBL3886138

CCOCc1ncccc1C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.49
TDP1 Q9NUW8 1/20 0.49
L3MBTL1 Q9Y468 4/20 0.47
ALDH1A1 P00352 4/20 0.47
ALOX15 P16050 2/20 0.47
NPSR1 Q6W5P4 2/20 0.47
MAPT P10636 2/20 0.47
CYP3A4 P08684 1/20 0.47
TSHR P16473 1/20 0.47
BLM P54132 1/20 0.47
AGER Q15109 1/20 0.47
HTT P42858 3/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
POLB P06746 1/20 0.47
SMN1; SMN2 Q16637 3/20 0.46
NAPRT Q6XQN6 2/20 0.46
LMNA P02545 1/20 0.46
MYC P01106 1/20 0.43
GAA P10253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28630876 0.84 ALDH1A1 (0.48) KDM4ETDP1L3MBTL1ALDH1A1ALOX15
SCHEMBL30638431 0.83 KDM4E (0.52) KDM4ETDP1L3MBTL1ALDH1A1ALOX15
SCHEMBL4608338 0.83 KDM4E (0.52) KDM4ETDP1L3MBTL1ALDH1A1ALOX15
SCHEMBL123202 0.81 KDM4E (0.57) KDM4ETDP1L3MBTL1ALDH1A1ALOX15
SCHEMBL9694340 0.81 KDM4E (0.49) KDM4ETDP1L3MBTL1ALDH1A1ALOX15
Hydrochloric Acid SCHEMBL17746080 0.80 KDM4E (0.55) KDM4ETDP1L3MBTL1ALDH1A1ALOX15
SCHEMBL2589045 0.78 MAPT (0.61) KDM4ETDP1L3MBTL1ALDH1A1ALOX15
SCHEMBL30177224 0.78 MAPT (0.61) KDM4ETDP1L3MBTL1ALDH1A1ALOX15
SCHEMBL258368 0.78 KDM4E (0.53) KDM4ETDP1L3MBTL1ALDH1A1ALOX15
Acetic Acid SCHEMBL16666942 0.78 KDM4E (0.53) KDM4ETDP1L3MBTL1ALDH1A1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2111400-A1 PYRIDINE COMPOUNDS AND THEIR USE AS P2Y12 ANTAGONISTS. AstraZeneca AB (SE) 2009-10-28 EP disclosed
WO-2008085117-A1 PYRIDINE COMPOUNDS AND THEIR USE AS P2Y12 ANTAGONISTS. ASTRAZENECA AB (SE) 2008-07-17 WO disclosed